ARCHIVES

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 42 | November 19, 2010

Download PDF Visit The Full Archive

Related Articles

Ivax Paclitaxel To Remain On Market In Deal With BMS.

February 1, 2002

ASCO, COA Present Plans For Cancer CareBeyond the Fee-For-Service Pay Structure

January 24, 2014

In Brief: Cancer Prevention Fellowship Program Application Sought; Grant Funds Available

March 18, 1994

Administration to Request 3.9% Increase for NIH; 1.3% Raise For NCI In FY97

March 8, 1996

CCIRC Members Now Feel At Home In DCT

March 3, 1978

AACR Honors Nine Cancer Researchers, Clinicians.

March 31, 2000